-+ 0.00%
-+ 0.00%
-+ 0.00%

*Aurinia Pharmaceuticals To Acquire Kezar Life Sciences For $6.955 In Cash Per Share Plus A Contingent Value Right >AUPH KZR

Dow Jones·03/30/2026 12:00:00

Please log in to view news